Loading…
POAS
PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd
NYSE American· Healthcare· Medical Devices· CUSIP G7049C104
$0.17-0.48%Price as of Aug 29, 18:47 UTC · updated once a day, after the close
Key metrics
- Market cap
- $5.21M
- P/E
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- —
- Payout
- —
- EPS
- -$0.27
- ROE
- —
- Profit margin
- 0.00%
- Revenue growth
- +38.80%
- Beta
- —
- 52-week high
- $7.40
- 52-week low
- $0.15
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Indicators, year by year
The last 2 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2026 | 2025 |
|---|---|---|---|
| Year-end price | $0.17 | $3.43 | |
| P/S | — | 20.9x | 272.1x |
| P/B | — | 0.5x | — |
| EPS | — | -$0.39 | |
| Profit margin | — | -4662.26% | -3063.12% |
| ROE | — | -116.18% | — |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| AMIXAutonomix Medical, Inc. | $5.32 | — | 0.9x | — | -315.99% | $5.17M |
| PCSAProcessa Pharmaceuticals, Inc. | $1.84 | 2.8x | — | — | -464.20% | $5.14M |
| ERNAErnexa Therapeutics Inc. | $4.57 | — | 0.8x | — | -320.72% | $5.33M |
| BRTXBioRestorative Therapies, Inc. | $0.20 |
About the company
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.
- 10
- Singapore, Singapore
Company description provided by Yahoo Finance.